Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This study will determine the effectiveness of various combinations of psychosocial therapy
and risperidone treatment in improving work or school performance in people with
first-episode schizophrenia.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, Los Angeles
Collaborators:
Janssen Scientific Affairs, LLC National Institute of Mental Health (NIMH)